Newbridge Financial Services Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Newbridge Financial Services Group’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4	Closed	-$1.43K	–	1177
2023 Q3	$1.43K	Hold	4	–	–	﹤0.01%	1122
2023 Q2	$1.52K	Hold	4	–	–	﹤0.01%	1171
2023 Q1	$1.92K	Hold	4	–	–	﹤0.01%	1199
2022 Q4	$1.68K	Hold	4	–	–	﹤0.01%	1246
2022 Q3	$2K	Sell	4 -6	-60%	-$2.99K	﹤0.01%	1177
2022 Q2	$5K	Hold	10	–	–	﹤0.01%	997
2022 Q1	$6K	Sell	10 -2	-17%	-$1.21K	﹤0.01%	1049
2021 Q4	$9K	Buy	12 +6	+100%	+$4.49K	﹤0.01%	929
2021 Q3	$4K	Hold	6	–	–	﹤0.01%	1044
2021 Q2	$4K	Hold	6	–	–	﹤0.01%	1149
2021 Q1	$3K	Buy	6 +1	+20%	+$592	﹤0.01%	1105
2020 Q4	$3K	Hold	5	–	–	﹤0.01%	908
2020 Q3	$3K	Buy	+5	New	+$2.53K	﹤0.01%	864

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Newbridge Financial Services Group's BIO Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2023, closing a stake of 4 shares — an estimated $1.43K sold.

Newbridge Financial Services Group first reported a position in BIO in Q3 2020 and held it in 13 quarters. The position peaked at $9K in Q4 2021. 484 funds tracked by Wall St. Rank hold BIO as of Q4 2023.

Newbridge Financial Services Group reported no remaining Bio-Rad Laboratories Class A position as of Q4 2023 after selling out during the quarter.
Newbridge Financial Services Group sold 4 Bio-Rad Laboratories Class A shares in Q4 2023, an estimated $1.43K.
Newbridge Financial Services Group first reported a position in Bio-Rad Laboratories Class A in Q3 2020 and held it in 13 quarters.
Newbridge Financial Services Group's Bio-Rad Laboratories Class A position peaked at $9K in Q4 2021.
484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.